A detailed history of Arrowstreet Capital, Limited Partnership transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 301,646 shares of CPRX stock, worth $6.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
301,646
Holding current value
$6.52 Million
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.19 - $21.35 $4.58 Million - $6.44 Million
301,646 New
301,646 $6 Million
Q1 2024

May 15, 2024

BUY
$13.18 - $17.11 $170,298 - $221,078
12,921 New
12,921 $206,000
Q3 2023

Nov 14, 2023

BUY
$11.69 - $15.02 $967,277 - $1.24 Million
82,744 Added 133.55%
144,699 $1.69 Million
Q2 2023

Aug 14, 2023

SELL
$11.5 - $18.08 $1.22 Million - $1.91 Million
-105,832 Reduced 63.08%
61,955 $833,000
Q1 2023

May 15, 2023

BUY
$14.34 - $21.05 $2.41 Million - $3.53 Million
167,787 New
167,787 $2.78 Million
Q2 2022

Aug 15, 2022

SELL
$6.23 - $8.57 $1.84 Million - $2.53 Million
-295,603 Reduced 93.8%
19,548 $137,000
Q1 2022

May 13, 2022

BUY
$5.31 - $8.31 $738,631 - $1.16 Million
139,102 Added 79.01%
315,151 $2.61 Million
Q4 2021

Feb 14, 2022

BUY
$5.21 - $7.45 $756,747 - $1.08 Million
145,249 Added 471.59%
176,049 $1.19 Million
Q3 2021

Nov 12, 2021

BUY
$4.85 - $6.04 $149,380 - $186,032
30,800 New
30,800 $163,000
Q1 2021

May 14, 2021

SELL
$3.45 - $4.69 $1.02 Million - $1.38 Million
-295,292 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$2.97 - $3.83 $877,017 - $1.13 Million
295,292 New
295,292 $986,000
Q3 2020

Nov 12, 2020

SELL
$2.97 - $5.08 $188,298 - $322,072
-63,400 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$3.48 - $5.05 $220,632 - $320,170
63,400 New
63,400 $293,000
Q1 2020

May 15, 2020

SELL
$2.61 - $5.21 $1.91 Million - $3.81 Million
-731,259 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$3.67 - $5.7 $2.68 Million - $4.17 Million
731,259 New
731,259 $2.74 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.